Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Sex, ethnicity and their impact on disease course and clinical outcomes in Canadian patients with autoimmune hepatitis
FY 2023-24
Summary
Sex, ethnicity and their impact on disease course and clinical outcomes in Canadian patients with autoimmune hepatitis
Autoimmune hepatitis (AIH) is a rare, chronic liver disease characterized by damage of the liver tissue caused by the immune system attacking liver cells. The disease may eventually lead to liver scarring and failure with some patients requiring a liver transplant. Previous literature has demonstrated a higher representation of Indigenous patients with AIH relative to their population in British Columbia, but it is unclear if these trends persist across Canada. There is a lack of studies focusing on Indigenous groups that, similar to other autoimmune liver diseases, may have worse clinical outcomes. AIH also affects both sexes, but female patients are 3 to 4 times more frequent than male patients. Although, studies have shown conflicting results regarding the influence of sex on clinical outcomes. To date, there are no national studies comparing associations between sex, ethnicity and disease outcomes in patients with AIH across Canada.
We aim to examine the prevalence of AIH by sex and ethnicity and explore possible associations and differences between sex, ethnicity and clinical outcomes. This study will be carried out using data collected under the Canadian Network for Autoimmune Liver Disease (CaNAL) which is a national registry of over 1000 patients with AIH containing data collected from liver centres across Canada. Clinical outcomes will be defined as the development of liver scarring and damage, need in liver transplant, and liver-related death. We anticipate that gaining insight into the associations between determinants of health, such as sex and ethnicity and disease outcomes will improve efforts at identifying at-risk groups.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506181
Name
Shreekumar Devika
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Sex, ethnicity and their impact on disease course and clinical outcomes in Canadian patients with autoimmune hepatitis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune Hepatitis; Autoimmune Liver Disease; Cirrhosis; Decompensation; Ethnicity; Liver Transplant; Prevalence; Sex; Survival
Abstract
Sex, ethnicity and their impact on disease course and clinical outcomes in Canadian patients with autoimmune hepatitis
Autoimmune hepatitis (AIH) is a rare, chronic liver disease characterized by damage of the liver tissue caused by the immune system attacking liver cells. The disease may eventually lead to liver scarring and failure with some patients requiring a liver transplant. Previous literature has demonstrated a higher representation of Indigenous patients with AIH relative to their population in British Columbia, but it is unclear if these trends persist across Canada. There is a lack of studies focusing on Indigenous groups that, similar to other autoimmune liver diseases, may have worse clinical outcomes. AIH also affects both sexes, but female patients are 3 to 4 times more frequent than male patients. Although, studies have shown conflicting results regarding the influence of sex on clinical outcomes. To date, there are no national studies comparing associations between sex, ethnicity and disease outcomes in patients with AIH across Canada.
We aim to examine the prevalence of AIH by sex and ethnicity and explore possible associations and differences between sex, ethnicity and clinical outcomes. This study will be carried out using data collected under the Canadian Network for Autoimmune Liver Disease (CaNAL) which is a national registry of over 1000 patients with AIH containing data collected from liver centres across Canada. Clinical outcomes will be defined as the development of liver scarring and damage, need in liver transplant, and liver-related death. We anticipate that gaining insight into the associations between determinants of health, such as sex and ethnicity and disease outcomes will improve efforts at identifying at-risk groups.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shreekumar, Devika
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~